About
MED I (Thailand) Co. Ltd
MED I (Thailand) provides GMP-standard oncology care — the whole package of radiopharmaceutical care, from equipment and facility planning to installation and maintenance — across ASEAN and South Asia.
Our story
Good Manufacturing Practice (GMP) is a system for ensuring products are consistently produced and controlled to quality standards, minimizing risks that can't be eliminated by testing the final product alone. MED I (Thailand) was built around that discipline: we provide GMP-standard equipment, facility planning, installation, and maintenance — the whole package of radiopharmaceutical care, not isolated equipment sales.
What we do
Our work follows the radiopharmaceutical value chain end to end:facility design →cyclotron isotope production →synthesis →GMP radiopharmacy production →quality control →radiation protection →molecular imaging →theranostics.
Partner network
Specialists team
J. Paul Shea, PhD
PhD Medicinal Chemist
Radiochemistry & PET Tracer Development — Luminare Molecular
J. Paul Shea leads radiochemistry and PET tracer development for the Luminare Molecular team, bringing 20+ years of experience in pharmaceutical discovery and development, including work at Bristol-Myers Squibb and across biotechnology and contract research organizations. He has spent 20 years in PET imaging specifically, including as VP Clinical Research at PETNet Solutions (Siemens) and VP Regulatory Affairs at CTI Molecular Imaging (Siemens). He remains active in the broader PET research community.
John P. Doumitt, PE
BS Professional Engineer (Industrial Engineering), MS Management (Purdue University)
GMP Facility Design & Construction Management
John P. Doumitt brings 20+ years of experience in PET GMP facility design, construction management, logistics, and general operations. He has served as Logistics Manager and Director of Field Operations for Syncor (Cardinal Health) and led a $15M operations upgrade program for IBA Molecular to meet FDA-mandated GMP standards. His project history includes advising a global contract research organization on a pre-clinical imaging center — concept to completion in 10 months — and designing the GMP KKUH and NGHA Jeddah radiopharmaceutical production facilities.
Farhad Karimi, PhD
PhD Organic Radiochemist, Uppsala University (IMANET PET Center)
Vice President, Radiochemistry & Regulatory Affairs — Luminare Molecular
Farhad Karimi has 20+ years of experience in the GMP production of PET tracers, having operated GMP PET production sites in the United States (Harvard University) and Australia (ANSTO). His research background is concentrated in novel 18F, 11C, and 68Ga tracers, and he leads radiochemistry and regulatory affairs for Luminare Molecular.
Nicola "Nick" Ceccomancini
GMP Radiopharmacy Consulting
Nicola Ceccomancini is the former Managing Director of Cyclomedical East Africa Ltd. and founder & CEO of A.R.T. — Advanced Radioisotopes Technologies, Italy. He brings 20+ years of experience in radiopharmaceuticals, with strong interpretation of regulatory and quality issues across corporate business activities and GMP consulting engagements.
Salman Milibari
BS Nuclear Engineering
Cyclotron Operations
Salman Milibari brings 35+ years of experience in cyclotron operation, including 20+ years as Head of the Cyclotron Section at King Faisal Specialist Hospital, Riyadh, and 25+ years as an Advisor to the International Atomic Energy Agency (IAEA) on Accelerator Safety. He is certified by the KSA National Center for Radiation Protection (2018).
Mario Malinconico
Radiation Protection
Mario Malinconico specializes in radiation protection for radiopharmacy and nuclear medicine facilities, supporting MED I (Thailand)’s Comecer hot-cell and shielding installations from specification through commissioning.
Anchali Krisanachinda, PhD
PhD, FIOMP, FIUPESM
Medical Physics — Thailand
Anchali Krisanachinda is a leading figure in Thai medical physics, a Fellow of the International Organization for Medical Physics (FIOMP) and a Fellow of the International Union for Physical and Engineering Sciences in Medicine (FIUPESM). Her involvement grounds MED I (Thailand)’s radiopharmacy and molecular imaging programs in the standards and regulatory expectations of the Thai medical physics community.
Rub Nawaz
B.S. Diagnostic Radiology
PET-CT, Cyclotron & Radiochemistry Consultant
Rub Nawaz is Manager of the Department of PET-CT Cyclotron & Radiochemistry and Head of Research & Scientific Collaborations at his home institution, and a Senior Clinical Application Specialist for PET/CT, CT & MRI with BIOS Pakistan (United Imaging Healthcare). He consults on PET-CT and cyclotron facility design, shielding, and equipment procurement, and supervises production and quality control of organ-specific radiopharmaceuticals — including 18F-PSMA 1007, 18F-FLT, 18F-FES, 18F-NaF, and 18F-Choline — using Neptis synthesis modules. He completed ABT factory training on cyclotron operations and radiochemistry in Knoxville, Tennessee, and holds PNRA certification for quality assurance of medical imaging modalities.
Company facts
Legal entity: MED I (Thailand) Co. Ltd.Contact us →

